AU2006286897A1 - Pyrazolo [3 , 4-d] azepine derivatives as histamine H3 antagonists - Google Patents

Pyrazolo [3 , 4-d] azepine derivatives as histamine H3 antagonists Download PDF

Info

Publication number
AU2006286897A1
AU2006286897A1 AU2006286897A AU2006286897A AU2006286897A1 AU 2006286897 A1 AU2006286897 A1 AU 2006286897A1 AU 2006286897 A AU2006286897 A AU 2006286897A AU 2006286897 A AU2006286897 A AU 2006286897A AU 2006286897 A1 AU2006286897 A1 AU 2006286897A1
Authority
AU
Australia
Prior art keywords
methanol
mixture
alkyl
aryl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006286897A
Other languages
English (en)
Inventor
Mark James Bamford
David Matthew Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2006286897A1 publication Critical patent/AU2006286897A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2006286897A 2005-07-06 2006-07-04 Pyrazolo [3 , 4-d] azepine derivatives as histamine H3 antagonists Abandoned AU2006286897A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0513886.2 2005-07-06
GBGB0513886.2A GB0513886D0 (en) 2005-07-06 2005-07-06 Novel compounds
PCT/EP2006/006613 WO2007025596A1 (en) 2005-07-06 2006-07-04 Pyrazolo [3 , 4-d] azepine derivatives as histamine h3 antagonists

Publications (1)

Publication Number Publication Date
AU2006286897A1 true AU2006286897A1 (en) 2007-03-08

Family

ID=34856781

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006286897A Abandoned AU2006286897A1 (en) 2005-07-06 2006-07-04 Pyrazolo [3 , 4-d] azepine derivatives as histamine H3 antagonists

Country Status (27)

Country Link
US (1) US7888347B2 (cg-RX-API-DMAC7.html)
EP (1) EP1899350B1 (cg-RX-API-DMAC7.html)
JP (1) JP5145218B2 (cg-RX-API-DMAC7.html)
KR (1) KR20080037651A (cg-RX-API-DMAC7.html)
CN (1) CN101258154B (cg-RX-API-DMAC7.html)
AT (1) ATE467636T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006286897A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0612719A2 (cg-RX-API-DMAC7.html)
CA (1) CA2614232A1 (cg-RX-API-DMAC7.html)
CR (1) CR9622A (cg-RX-API-DMAC7.html)
CY (1) CY1110711T1 (cg-RX-API-DMAC7.html)
DE (1) DE602006014273D1 (cg-RX-API-DMAC7.html)
DK (1) DK1899350T3 (cg-RX-API-DMAC7.html)
EA (1) EA013600B1 (cg-RX-API-DMAC7.html)
ES (1) ES2345841T3 (cg-RX-API-DMAC7.html)
GB (1) GB0513886D0 (cg-RX-API-DMAC7.html)
HR (1) HRP20100401T1 (cg-RX-API-DMAC7.html)
IL (1) IL188184A0 (cg-RX-API-DMAC7.html)
MA (1) MA29623B1 (cg-RX-API-DMAC7.html)
MX (1) MX2008000383A (cg-RX-API-DMAC7.html)
NO (1) NO20080563L (cg-RX-API-DMAC7.html)
PL (1) PL1899350T3 (cg-RX-API-DMAC7.html)
PT (1) PT1899350E (cg-RX-API-DMAC7.html)
SI (1) SI1899350T1 (cg-RX-API-DMAC7.html)
UA (1) UA93047C2 (cg-RX-API-DMAC7.html)
WO (1) WO2007025596A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200710798B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9108948B2 (en) 2006-06-23 2015-08-18 Abbvie Inc. Cyclopropyl amine derivatives
JP5203360B2 (ja) 2006-06-23 2013-06-05 アボット・ラボラトリーズ ヒスタミンｈ３受容体調節剤としてのシクロプロピルアミン誘導体
MX2010002938A (es) 2007-09-24 2010-04-01 Comentis Inc Derivados de (3-hidroxi-4-amino-butan-2-il)-3-(2-tiazol-2-il-pirro lidin-1-carbonil)benzamida y compuestos relacionados como inhibidores de beta-secretasa para tratar enfermedad de alzheimer.
US9186353B2 (en) 2009-04-27 2015-11-17 Abbvie Inc. Treatment of osteoarthritis pain
WO2012037258A1 (en) 2010-09-16 2012-03-22 Abbott Laboratories Processes for preparing 1,2-substituted cyclopropyl derivatives
CN102952139B (zh) * 2011-08-30 2016-08-10 上海药明康德新药开发有限公司 反式-3a-氟吡咯烷[3,4-C]并环化合物及其制备方法
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
EP2647377A1 (en) 2012-04-06 2013-10-09 Sanofi Use of an h3 receptor antagonist for the treatment of alzheimer's disease
JO3407B1 (ar) 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين
US9910887B2 (en) * 2013-04-25 2018-03-06 Facebook, Inc. Variable search query vertical access
KR20190040140A (ko) * 2016-05-25 2019-04-17 아카나 테라퓨틱스, 엘티디. 질환의 치료를 위한 융합된 비시클릭 화합물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010079778A (ko) * 1998-09-09 2001-08-22 이시하라 겐조 제초제로 유용한 융합-벤젠 유도체
EP1173438A1 (en) * 1999-04-16 2002-01-23 Novo Nordisk A/S Substituted imidazoles, their preparation and use
JP2001220390A (ja) 2000-02-09 2001-08-14 Yamanouchi Pharmaceut Co Ltd 縮合ピラゾール誘導体
WO2003104235A1 (en) 2002-06-06 2003-12-18 Novo Nordisk A/S Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]pyrazines and decahydropyrazino[1,2-a]azepines
US6770597B2 (en) 2002-07-17 2004-08-03 Ishihara Sangyo Kaisha, Ltd. Benzohydrazide derivatives as herbicides and desiccant compositions containing them
US20060135508A1 (en) 2002-07-25 2006-06-22 Manuela Villa Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
AU2003256793A1 (en) * 2002-08-20 2004-03-11 Eli Lilly And Company Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses
GB0224083D0 (en) 2002-10-16 2002-11-27 Glaxo Group Ltd Novel compounds
GB0224557D0 (en) 2002-10-22 2002-11-27 Glaxo Group Ltd Novel compounds
TWI323256B (en) 2002-12-20 2010-04-11 Glaxo Group Ltd Novel benzazepine derivatives and pharmaceutical compositions comprising said compounds
EA010905B1 (ru) * 2003-09-17 2008-12-30 Янссен Фармацевтика Н.В. Сопряжённые гетероциклические соединения
GB0329214D0 (en) 2003-12-17 2004-01-21 Glaxo Group Ltd Novel compounds
GB0405628D0 (en) 2004-03-12 2004-04-21 Glaxo Group Ltd Novel compounds
GB0408083D0 (en) 2004-04-08 2004-05-12 Glaxo Group Ltd Novel compounds
PE20060302A1 (es) 2004-06-18 2006-04-08 Glaxo Group Ltd Derivados de benzazepina como antagonistas del receptor h3
GB0418267D0 (en) 2004-08-16 2004-09-15 Glaxo Group Ltd Novel compounds
JP2008523006A (ja) 2004-12-07 2008-07-03 グラクソ グループ リミテッド インデニル誘導体および神経学的障害の治療のためのそれらの使用
AU2006224440A1 (en) 2005-03-14 2006-09-21 Glaxo Group Limited Fused thiazole derivatives having affinity for the histamine H3 receptor

Also Published As

Publication number Publication date
CN101258154B (zh) 2011-01-19
NO20080563L (no) 2008-02-01
CA2614232A1 (en) 2007-03-08
WO2007025596A1 (en) 2007-03-08
CN101258154A (zh) 2008-09-03
CR9622A (es) 2008-04-10
HRP20100401T1 (hr) 2010-09-30
JP2009500366A (ja) 2009-01-08
KR20080037651A (ko) 2008-04-30
EP1899350A1 (en) 2008-03-19
ATE467636T1 (de) 2010-05-15
US20080176832A1 (en) 2008-07-24
ES2345841T3 (es) 2010-10-04
PT1899350E (pt) 2010-07-21
DE602006014273D1 (de) 2010-06-24
EA200800264A1 (ru) 2008-06-30
DK1899350T3 (da) 2010-09-06
SI1899350T1 (sl) 2010-09-30
UA93047C2 (ru) 2011-01-10
BRPI0612719A2 (pt) 2010-11-30
JP5145218B2 (ja) 2013-02-13
PL1899350T3 (pl) 2010-10-29
CY1110711T1 (el) 2015-06-10
ZA200710798B (en) 2008-11-26
GB0513886D0 (en) 2005-08-10
EA013600B1 (ru) 2010-06-30
EP1899350B1 (en) 2010-05-12
MA29623B1 (fr) 2008-07-01
IL188184A0 (en) 2008-03-20
MX2008000383A (es) 2008-03-07
US7888347B2 (en) 2011-02-15

Similar Documents

Publication Publication Date Title
EP1802307B1 (en) Pyrrolidine derivatives as histamine receptors ligands
EP1615909B1 (en) Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
WO2005040144A1 (en) Novel compounds
US20070208005A1 (en) Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h3 receptor
US7638631B2 (en) Methylene dipiperidine derivatives
EP1899350B1 (en) Pyrazolo [3 , 4-d]azepine derivatives as histamine h3 antagonists
EP1646620A1 (en) Substituted piperidines as histamine h3 receptor ligands
EP1756094A1 (en) 3-cycloalkylbenzazepines as histamine h3 antagonists
EP1858900B1 (en) Fused thiazole derivatives having affinity for the histamine h3 receptor
WO2006061193A1 (en) Indenyl derivatives and use thereof for the treatment of neurological disorders
CN101171256A (zh) 具有组胺h3受体亲和性的稠合噻唑衍生物

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted